ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2026
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss.
Hannah Zillikens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.